tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

KHTRF Stock Latest News

Knight Therapeutics price target lowered to C$6.25 from C$6.75 at Stifel
The FlyKnight Therapeutics price target lowered to C$6.25 from C$6.75 at Stifel
4d ago
Knight Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Knight Therapeutics Reports Q3 2024 Financial Results
5d ago
Knight Therapeutics downgraded to Hold from Buy at Mackie Research Capital
PremiumThe Fly
Knight Therapeutics downgraded to Hold from Buy at Mackie Research Capital
5d ago
Knight Therapeutics reports Q3 EPS C$0.00 vs. C$0.09 last year
PremiumThe Fly
Knight Therapeutics reports Q3 EPS C$0.00 vs. C$0.09 last year
6d ago
Knight Therapeutics sees FY24 revenue C$355M-C$365M
PremiumThe Fly
Knight Therapeutics sees FY24 revenue C$355M-C$365M
6d ago
KHTRF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsKHTRF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8d ago
Knight Therapeutics announces approval of Minjuvi in Mexico
Premium
The Fly
Knight Therapeutics announces approval of Minjuvi in Mexico
29d ago
Ardelyx (ARDX) Beats Expectations in Q2 and Offers Promising Outlook
Premium
Market News
Ardelyx (ARDX) Beats Expectations in Q2 and Offers Promising Outlook
3M ago
ARDX
Knight Therapeutics upgraded to Buy from Accumulate at Stifel
PremiumThe Fly
Knight Therapeutics upgraded to Buy from Accumulate at Stifel
3M ago
Knight Therapeutics price target raised to C$8 from C$7.50 at Raymond James
PremiumThe Fly
Knight Therapeutics price target raised to C$8 from C$7.50 at Raymond James
3M ago
Knight Therapeutics sees FY24 revenue C$355M-C$365M
PremiumThe Fly
Knight Therapeutics sees FY24 revenue C$355M-C$365M
3M ago
Knight Therapeutics reports Q2 EPS (C$0.02) vs. C$0.02 last year
PremiumThe Fly
Knight Therapeutics reports Q2 EPS (C$0.02) vs. C$0.02 last year
3M ago
Knight Therapeutics Hits Record Q2 Revenues
PremiumCompany AnnouncementsKnight Therapeutics Hits Record Q2 Revenues
3M ago
Is KHTRF a Buy, Before Earnings?
Premium
Pre-Earnings
Is KHTRF a Buy, Before Earnings?
3M ago
Knight Therapeutics announces Normal Course Issuer Bid
Premium
The Fly
Knight Therapeutics announces Normal Course Issuer Bid
4M ago
Knight Therapeutics price target raised to C$5.75 from C$5.40 at Stifel
PremiumThe Fly
Knight Therapeutics price target raised to C$5.75 from C$5.40 at Stifel
6M ago
Knight Therapeutics reports Q1 EPS C$0.13 vs. C$0.18 last year
PremiumThe Fly
Knight Therapeutics reports Q1 EPS C$0.13 vs. C$0.18 last year
6M ago
Knight Therapeutics enters supply, distribution agreement with Ironshore
PremiumThe Fly
Knight Therapeutics enters supply, distribution agreement with Ironshore
6M ago
Knight Therapeutics Announces Q1 Growth and Expansion
PremiumCompany Announcements
Knight Therapeutics Announces Q1 Growth and Expansion
6M ago
Knight Therapeutics Shareholders Back Directors and Auditors
PremiumCompany AnnouncementsKnight Therapeutics Shareholders Back Directors and Auditors
6M ago
Knight Therapeutics price target raised to C$5.40 from C$5.25 at Stifel
Premium
The Fly
Knight Therapeutics price target raised to C$5.40 from C$5.25 at Stifel
7M ago
Knight Therapeutics resumed with a Buy at Canaccord
Premium
The Fly
Knight Therapeutics resumed with a Buy at Canaccord
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >